Preclinical evidence has shown that intranasal insulin may also ameliorate cognitive deficits in 6-hydroxylase dopamine (6-OHDA)-induced rat models of PD by regulating the Akt/Glycogen Synthase Kinase 3 Beta (GSK3β) signaling pathway [50]. The gene discussed is INS; the disease is Parkinson disease.